The Efficacy of Intravitreal Povidone Iodine Application in Experimental Staphylococcus epidermidis Endophthalmitis

被引:19
作者
Brozou, Catherine G. [1 ]
Karabatakis, Vasilios [1 ]
Giannousis, Michalis [2 ]
Mandraveli, Kalliopi [2 ]
Karkavelas, George [3 ]
Alexiou-Daniel, Styliani [2 ]
机构
[1] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Sch Med, Lab Expt Ophthalmol, GR-54636 Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Sch Med, Dept Microbiol, GR-54636 Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54636 Thessaloniki, Greece
关键词
Staphylococcus epidermidis; Endophthalmitis; Povidone iodine; MOXIFLOXACIN;
D O I
10.1159/000217721
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim: The aim of the current study is to evaluate the role of povidone iodine (PVI) in the management of experimental bacterial endophthalmitis in young rabbits. Method: Twenty white rabbits were used. Colony-forming units (CFU) of Staphylococcus epidermidis were injected intravitreally into the right eye of each animal. Injected eyes were evaluated clinically daily (anterior and posterior segment examination), and when clinical signs of endophthalmitis appeared, an injection of 0.1 ml PVI was made intravitreally. In group 1 (n = 10), the injected concentration of PVI was 0.1%, and in group 2 (n = 10) the concentration was 0.2%. At the end of the observation period, vitreous sample culture was made, and vitreous and retina specimens were taken for light histology examination as well. Results: Group 1 eyes did not show any signs of clinical improvement. Vitreous culture showed the presence of 10(8) CFU/ml of S. epidermidis. Histological examination indicated acute inflammation. Group 2 animals presented a clear gradual regression of the inflammation. Vitreous culture for S. epidermidis proved to be sterile. Histological examination indicated chronic inflammation. Conclusions: Intravitreal injection of 0.2% PVI is likely to inhibit bacterial endophthalmitis of rabbit eyes due to S. epidermidis. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:181 / 185
页数:5
相关论文
共 16 条
[1]   Prevention of endophthalmitis [J].
Buzard, K ;
Liapis, S .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2004, 30 (09) :1953-1959
[2]   Bacterial endophthalmitis prophylaxis for cataract surgery -: An evidence-based update [J].
Ciulla, TA ;
Starr, MB ;
Masket, S .
OPHTHALMOLOGY, 2002, 109 (01) :13-24
[3]  
*END VITR STUD GRO, 1995, ARCH OPHTHALMOL-CHIC, V113, P1749
[4]   Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis [J].
Engelbert, M ;
de Kaspar, HM ;
Thiel, M ;
Grasbon, T ;
Ta, CN ;
Schulze-Schwering, M ;
Klauss, V ;
Kampik, A .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 242 (04) :313-320
[5]   Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model [J].
Ermis, SS ;
Cetinkaya, Z ;
Kiyic, H ;
Ozturk, F .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 205 (03) :223-229
[6]   Postoperative endophthalmitis [J].
Hanscom, TA .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (04) :542-546
[7]   In vitro comparison of ciprofloxacin, ofloxacin, and povidone-iodine for surgical prophylaxis [J].
Keverline, MR ;
Kowalski, RP ;
Dhaliwal, DK .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2002, 28 (06) :915-916
[8]   Intracameral Vigamox® (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model [J].
Kowalski, RP ;
Romanowski, EG ;
Mah, FS ;
Yates, KA ;
Gordon, YJ .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 140 (03) :497-504
[9]   The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis [J].
McCormick, CC ;
Dajcs, JJ ;
Reed, JM ;
Marquart, ME ;
O'Callaghan, RJ .
CURRENT EYE RESEARCH, 2006, 31 (03) :225-230
[10]   Treatment of experimental Staphylococcus epidermidis endophthalmitis with oral trovafloxacin [J].
Ng, EWM ;
Samiy, N ;
Ruoff, KL ;
Cousins, FV ;
Hooper, DC ;
Von Gunten, S ;
D'Amico, DJ ;
Baker, AS .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1998, 126 (02) :278-287